KD inhibits inflammatory responses and regulates bile acid homeostasis to alleviate EE-induced cholestatic liver injury in rats by reducing the expression of IL-1β, IL-6 and suppressing EE-mediated reduction in FXR in rats. This evidence concerns the gene NR1H4 and digestive system neoplasm.